EP2131852 - TREATMENT OF INFLAMMATION AND/OR ENDOTOXIC SHOCK [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 07.09.2018 Database last updated on 03.09.2024 | |
Former | The patent has been granted Status updated on 29.09.2017 | ||
Former | Grant of patent is intended Status updated on 02.11.2016 | Most recent event Tooltip | 05.06.2020 | Lapse of the patent in a contracting state New state(s): HU, PT | published on 08.07.2020 [2020/28] | Applicant(s) | For all designated states Oxford University Innovation Limited Buxton Court 3 West Way Botley Oxford OX2 0JB / GB | [2017/10] |
Former [2016/32] | For all designated states Oxford University Innovation Limited Buxton Court 3 West Way Botley Oxford OX2 0SZ / GB | ||
Former [2009/51] | For all designated states ISIS Innovation Limited Ewert Place, Ewert House Summertown Oxford OX2 7SG / GB | Inventor(s) | 01 /
GREAVES, David, R. Sir William Dunn School of Phathology University of Oxford South Parks Road Oxford OX1 3RE / GB | 02 /
RUSS, Andreas Department of Biochemistry University of Oxford South Parks Road Oxford OX1 3QU / GB | 03 /
CASH, Jenna, L. Sir William Dunn School of Pathology University of Oxford South Parks Road Oxford OX1 3RE / GB | [2017/44] |
Former [2009/51] | 01 /
GREAVES, David, R. Sir William Dunn School of Phathology University of Oxford South Parks Road Oxford OX1 3RE / GB | ||
02 /
RUSS, Andreas Department of Biochemistry University of Oxford South Parks Road Oxford OX1 3QU / GB | |||
03 /
CASH, Jenna, L. Sir William Dunn School of Pathology University of Oxford South Parks Road Oxford OX1 3RE / GB | Representative(s) | Barker Brettell LLP 100 Hagley Road Edgbaston Birmingham B16 8QQ / GB | [N/P] |
Former [2017/44] | Atkinson, Jennifer, et al Barker Brettell LLP 100 Hagley Road Edgbaston Birmingham B16 8QQ / GB | ||
Former [2009/51] | Atkinson, Jennifer, et al Barker Brettell LLP 138 Hagley Road Edgbaston Birmingham B16 9PW / GB | Application number, filing date | 08718857.9 | 25.03.2008 | [2009/51] | WO2008GB01020 | Priority number, date | GB20070005488 | 22.03.2007 Original published format: GB 0705488 | [2009/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008114037 | Date: | 25.09.2008 | Language: | EN | [2008/39] | Type: | A1 Application with search report | No.: | EP2131852 | Date: | 16.12.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.09.2008 takes the place of the publication of the European patent application. | [2009/51] | Type: | B1 Patent specification | No.: | EP2131852 | Date: | 01.11.2017 | Language: | EN | [2017/44] | Search report(s) | International search report - published on: | EP | 25.09.2008 | Classification | IPC: | A61K38/04, A61P29/00, A61P31/00, C07K7/04 | [2009/51] | CPC: |
A61K38/08 (EP,US);
A61K38/10 (US);
A61P1/04 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P11/02 (EP);
A61P11/06 (EP);
A61P13/12 (EP);
A61P17/02 (EP);
A61P17/04 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P27/02 (EP);
A61P27/16 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P31/10 (EP);
A61P31/12 (EP);
A61P31/18 (EP);
A61P33/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P39/00 (EP);
A61P39/02 (EP);
A61P43/00 (EP);
A61P5/14 (EP);
A61P7/04 (EP);
A61P7/06 (EP);
C07K14/47 (EP,US);
C07K7/06 (US);
C07K7/08 (US);
A61K38/00 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2017/44] |
Former [2009/51] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | BEHANDLUNG VON ENTZÜNDUNGEN UND/ODER ENDOTOXISCHEM SCHOCK | [2016/38] | English: | TREATMENT OF INFLAMMATION AND/OR ENDOTOXIC SHOCK | [2009/51] | French: | TRAITEMENT D'UNE INFLAMMATION ET/OU D'UN CHOC ENDOTOXIQUE | [2009/51] |
Former [2009/51] | BEHANDLUNG VON ENTZÜNDUNG UND/ODER ENDOTOXISCHEM SCHOCK | Entry into regional phase | 01.10.2009 | National basic fee paid | 01.10.2009 | Designation fee(s) paid | 01.10.2009 | Examination fee paid | Examination procedure | 01.10.2009 | Amendment by applicant (claims and/or description) | 01.10.2009 | Examination requested [2009/51] | 01.02.2010 | Despatch of a communication from the examining division (Time limit: M04) | 26.05.2010 | Reply to a communication from the examining division | 07.06.2010 | Despatch of a communication from the examining division (Time limit: M06) | 04.04.2011 | Reply to a communication from the examining division | 27.09.2011 | Despatch of a communication from the examining division (Time limit: M04) | 17.05.2012 | Reply to a communication from the examining division | 12.04.2013 | Despatch of a communication from the examining division (Time limit: M06) | 22.10.2013 | Reply to a communication from the examining division | 13.10.2015 | Despatch of a communication from the examining division (Time limit: M04) | 21.03.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 27.05.2016 | Reply to a communication from the examining division | 03.11.2016 | Communication of intention to grant the patent | 27.02.2017 | Fee for grant paid | 27.02.2017 | Fee for publishing/printing paid | 27.02.2017 | Receipt of the translation of the claim(s) | Divisional application(s) | EP12152769.1 / EP2465522 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 01.02.2010 | Opposition(s) | 02.08.2018 | No opposition filed within time limit [2018/41] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 27.05.2016 | Request for further processing filed | 27.05.2016 | Full payment received (date of receipt of payment) Request granted | 08.06.2016 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 17.05.2012 | Request for further processing filed | 17.05.2012 | Full payment received (date of receipt of payment) Request granted | 29.05.2012 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 04.04.2011 | Request for further processing filed | 04.04.2011 | Full payment received (date of receipt of payment) Request granted | 15.04.2011 | Decision despatched | Fees paid | Renewal fee | 24.03.2010 | Renewal fee patent year 03 | 28.03.2011 | Renewal fee patent year 04 | 29.03.2012 | Renewal fee patent year 05 | 26.03.2013 | Renewal fee patent year 06 | 29.04.2014 | Renewal fee patent year 07 | 30.03.2015 | Renewal fee patent year 08 | 30.03.2016 | Renewal fee patent year 09 | 19.09.2017 | Renewal fee patent year 10 | Penalty fee | Additional fee for renewal fee | 31.03.2014 | 07   M06   Fee paid on   29.04.2014 | 31.03.2017 | 10   M06   Fee paid on   19.09.2017 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 25.03.2008 | AT | 01.11.2017 | CY | 01.11.2017 | CZ | 01.11.2017 | DK | 01.11.2017 | EE | 01.11.2017 | FI | 01.11.2017 | HR | 01.11.2017 | IT | 01.11.2017 | LT | 01.11.2017 | LV | 01.11.2017 | MC | 01.11.2017 | NL | 01.11.2017 | PL | 01.11.2017 | PT | 01.11.2017 | RO | 01.11.2017 | SE | 01.11.2017 | SI | 01.11.2017 | SK | 01.11.2017 | TR | 01.11.2017 | BG | 01.02.2018 | NO | 01.02.2018 | GR | 02.02.2018 | IS | 01.03.2018 | IE | 25.03.2018 | LU | 25.03.2018 | MT | 25.03.2018 | BE | 31.03.2018 | CH | 31.03.2018 | LI | 31.03.2018 | [2020/27] |
Former [2020/16] | AT | 01.11.2017 | |
CY | 01.11.2017 | ||
CZ | 01.11.2017 | ||
DK | 01.11.2017 | ||
EE | 01.11.2017 | ||
FI | 01.11.2017 | ||
HR | 01.11.2017 | ||
IT | 01.11.2017 | ||
LT | 01.11.2017 | ||
LV | 01.11.2017 | ||
MC | 01.11.2017 | ||
NL | 01.11.2017 | ||
PL | 01.11.2017 | ||
RO | 01.11.2017 | ||
SE | 01.11.2017 | ||
SI | 01.11.2017 | ||
SK | 01.11.2017 | ||
TR | 01.11.2017 | ||
BG | 01.02.2018 | ||
NO | 01.02.2018 | ||
GR | 02.02.2018 | ||
IS | 01.03.2018 | ||
IE | 25.03.2018 | ||
LU | 25.03.2018 | ||
MT | 25.03.2018 | ||
BE | 31.03.2018 | ||
CH | 31.03.2018 | ||
LI | 31.03.2018 | ||
Former [2020/08] | AT | 01.11.2017 | |
CY | 01.11.2017 | ||
CZ | 01.11.2017 | ||
DK | 01.11.2017 | ||
EE | 01.11.2017 | ||
FI | 01.11.2017 | ||
HR | 01.11.2017 | ||
IT | 01.11.2017 | ||
LT | 01.11.2017 | ||
LV | 01.11.2017 | ||
MC | 01.11.2017 | ||
NL | 01.11.2017 | ||
PL | 01.11.2017 | ||
RO | 01.11.2017 | ||
SE | 01.11.2017 | ||
SI | 01.11.2017 | ||
SK | 01.11.2017 | ||
BG | 01.02.2018 | ||
NO | 01.02.2018 | ||
GR | 02.02.2018 | ||
IS | 01.03.2018 | ||
IE | 25.03.2018 | ||
LU | 25.03.2018 | ||
MT | 25.03.2018 | ||
BE | 31.03.2018 | ||
CH | 31.03.2018 | ||
LI | 31.03.2018 | ||
Former [2019/12] | AT | 01.11.2017 | |
CY | 01.11.2017 | ||
CZ | 01.11.2017 | ||
DK | 01.11.2017 | ||
EE | 01.11.2017 | ||
FI | 01.11.2017 | ||
HR | 01.11.2017 | ||
IT | 01.11.2017 | ||
LT | 01.11.2017 | ||
LV | 01.11.2017 | ||
MC | 01.11.2017 | ||
NL | 01.11.2017 | ||
PL | 01.11.2017 | ||
RO | 01.11.2017 | ||
SE | 01.11.2017 | ||
SI | 01.11.2017 | ||
SK | 01.11.2017 | ||
BG | 01.02.2018 | ||
NO | 01.02.2018 | ||
GR | 02.02.2018 | ||
IS | 01.03.2018 | ||
IE | 25.03.2018 | ||
LU | 25.03.2018 | ||
BE | 31.03.2018 | ||
CH | 31.03.2018 | ||
LI | 31.03.2018 | ||
Former [2019/09] | AT | 01.11.2017 | |
CY | 01.11.2017 | ||
CZ | 01.11.2017 | ||
DK | 01.11.2017 | ||
EE | 01.11.2017 | ||
FI | 01.11.2017 | ||
HR | 01.11.2017 | ||
IT | 01.11.2017 | ||
LT | 01.11.2017 | ||
LV | 01.11.2017 | ||
MC | 01.11.2017 | ||
NL | 01.11.2017 | ||
PL | 01.11.2017 | ||
RO | 01.11.2017 | ||
SE | 01.11.2017 | ||
SI | 01.11.2017 | ||
SK | 01.11.2017 | ||
BG | 01.02.2018 | ||
NO | 01.02.2018 | ||
GR | 02.02.2018 | ||
IS | 01.03.2018 | ||
IE | 25.03.2018 | ||
LU | 25.03.2018 | ||
Former [2019/04] | AT | 01.11.2017 | |
CY | 01.11.2017 | ||
CZ | 01.11.2017 | ||
DK | 01.11.2017 | ||
EE | 01.11.2017 | ||
FI | 01.11.2017 | ||
HR | 01.11.2017 | ||
IT | 01.11.2017 | ||
LT | 01.11.2017 | ||
LV | 01.11.2017 | ||
MC | 01.11.2017 | ||
NL | 01.11.2017 | ||
PL | 01.11.2017 | ||
RO | 01.11.2017 | ||
SE | 01.11.2017 | ||
SI | 01.11.2017 | ||
SK | 01.11.2017 | ||
BG | 01.02.2018 | ||
NO | 01.02.2018 | ||
GR | 02.02.2018 | ||
IS | 01.03.2018 | ||
LU | 25.03.2018 | ||
Former [2018/52] | AT | 01.11.2017 | |
CY | 01.11.2017 | ||
CZ | 01.11.2017 | ||
DK | 01.11.2017 | ||
EE | 01.11.2017 | ||
FI | 01.11.2017 | ||
HR | 01.11.2017 | ||
IT | 01.11.2017 | ||
LT | 01.11.2017 | ||
LV | 01.11.2017 | ||
MC | 01.11.2017 | ||
NL | 01.11.2017 | ||
PL | 01.11.2017 | ||
RO | 01.11.2017 | ||
SE | 01.11.2017 | ||
SI | 01.11.2017 | ||
SK | 01.11.2017 | ||
BG | 01.02.2018 | ||
NO | 01.02.2018 | ||
GR | 02.02.2018 | ||
IS | 01.03.2018 | ||
Former [2018/41] | AT | 01.11.2017 | |
CY | 01.11.2017 | ||
CZ | 01.11.2017 | ||
DK | 01.11.2017 | ||
EE | 01.11.2017 | ||
FI | 01.11.2017 | ||
HR | 01.11.2017 | ||
IT | 01.11.2017 | ||
LT | 01.11.2017 | ||
LV | 01.11.2017 | ||
NL | 01.11.2017 | ||
PL | 01.11.2017 | ||
RO | 01.11.2017 | ||
SE | 01.11.2017 | ||
SK | 01.11.2017 | ||
BG | 01.02.2018 | ||
NO | 01.02.2018 | ||
GR | 02.02.2018 | ||
IS | 01.03.2018 | ||
Former [2018/39] | AT | 01.11.2017 | |
CY | 01.11.2017 | ||
CZ | 01.11.2017 | ||
DK | 01.11.2017 | ||
EE | 01.11.2017 | ||
FI | 01.11.2017 | ||
HR | 01.11.2017 | ||
IT | 01.11.2017 | ||
LT | 01.11.2017 | ||
LV | 01.11.2017 | ||
NL | 01.11.2017 | ||
PL | 01.11.2017 | ||
SE | 01.11.2017 | ||
SK | 01.11.2017 | ||
BG | 01.02.2018 | ||
NO | 01.02.2018 | ||
GR | 02.02.2018 | ||
IS | 01.03.2018 | ||
Former [2018/37] | AT | 01.11.2017 | |
CY | 01.11.2017 | ||
CZ | 01.11.2017 | ||
DK | 01.11.2017 | ||
EE | 01.11.2017 | ||
FI | 01.11.2017 | ||
HR | 01.11.2017 | ||
LT | 01.11.2017 | ||
LV | 01.11.2017 | ||
NL | 01.11.2017 | ||
PL | 01.11.2017 | ||
SE | 01.11.2017 | ||
SK | 01.11.2017 | ||
BG | 01.02.2018 | ||
NO | 01.02.2018 | ||
GR | 02.02.2018 | ||
IS | 01.03.2018 | ||
Former [2018/35] | AT | 01.11.2017 | |
CY | 01.11.2017 | ||
CZ | 01.11.2017 | ||
DK | 01.11.2017 | ||
EE | 01.11.2017 | ||
FI | 01.11.2017 | ||
HR | 01.11.2017 | ||
LT | 01.11.2017 | ||
LV | 01.11.2017 | ||
NL | 01.11.2017 | ||
SE | 01.11.2017 | ||
SK | 01.11.2017 | ||
BG | 01.02.2018 | ||
NO | 01.02.2018 | ||
GR | 02.02.2018 | ||
IS | 01.03.2018 | ||
Former [2018/24] | AT | 01.11.2017 | |
FI | 01.11.2017 | ||
HR | 01.11.2017 | ||
LT | 01.11.2017 | ||
LV | 01.11.2017 | ||
NL | 01.11.2017 | ||
SE | 01.11.2017 | ||
BG | 01.02.2018 | ||
NO | 01.02.2018 | ||
GR | 02.02.2018 | ||
IS | 01.03.2018 | ||
Former [2018/23] | AT | 01.11.2017 | |
FI | 01.11.2017 | ||
HR | 01.11.2017 | ||
LT | 01.11.2017 | ||
NL | 01.11.2017 | ||
SE | 01.11.2017 | ||
NO | 01.02.2018 | ||
GR | 02.02.2018 | ||
IS | 01.03.2018 | ||
Former [2018/22] | FI | 01.11.2017 | |
LT | 01.11.2017 | ||
NL | 01.11.2017 | ||
NO | 01.02.2018 | ||
Former [2018/21] | FI | 01.11.2017 | |
LT | 01.11.2017 | ||
NO | 01.02.2018 | Cited in | International search | [X] - WITTAMER ET AL, "The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2004), vol. 279, pages 9956 - 9962, XP002310263 [X] 23,26,27 * See page 9958 (Table 1 / peptides) * DOI: http://dx.doi.org/10.1074/jbc.M313016200 | [XD] - WITTAMER ET AL, "Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids", JOURNAL OF EXPERIMENTAL MEDICINE, (2003), vol. 198, pages 977 - 985, XP002310262 [XD] 23,26,27 * See page 980 (Figure 2B) * DOI: http://dx.doi.org/10.1084/jem.20030382 | [XD] - ZABEL ET AL, "Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2005), vol. 280, pages 34661 - 34666, XP002486778 [XD] 23,26,27 * See page 34661 (Abstract) and page 34664 (the peptide 141-155) * DOI: http://dx.doi.org/10.1074/jbc.M504868200 | [A] - KULIG ET AL, "Staphylococcus aureus-derived staphopain B, a potent cysteine protease activator of plasma chemerin", THE JOURNAL OF IMMUNOLOGY, (20070315), vol. 178, pages 3713 - 3720, XP002487265 [A] 1-28 * See pages 3715-3719 (Results and Discussion) * | [PA] - ROH ET AL, "Chemerin - a new adipokine that modulates adipogenesis via its own receptor", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (200708), vol. 362, pages 1013 - 1018, XP022249546 [PA] 1-28 * See page 1017 (right column, first paragraph) * DOI: http://dx.doi.org/10.1016/j.bbrc.2007.08.104 | by applicant | - COLMAN RW, BIOL CHEM., (200101), vol. 382, no. 1, pages 65 - 70 | - YAMASAKI K ET AL., FASEB J., (20061001), vol. 20, no. 12, pages 2068 - 2080 | - WITTAMER ET AL., J. BIOL. CHEM., (2004), vol. 279, no. 11, pages 9956 - 9962 |